Table 3 miR screening by TaqMan Low Density Arrays.

From: Changes in CD73, CD39 and CD26 expression on T-lymphocytes of ANCA-associated vasculitis patients suggest impairment in adenosine generation and turn-over

Up-regulation

Fold Change

Range

p-value

miR-193a-5p

1.37

0.91–2.07

0.047

miR-652

1.38

0.85–2.23

0.046

miR-93

1.39

0.96–2.01

0.041

miR-425

1.46

1.04–2.05

0.047

miR-671–3p

1.50

0.93–2.43

0.048

miR-484

1.53

1.18–1.99

0.019

miR-491–5p

1.60

1.16–2.22

0.031

miR-487a

1.60

0.99–2.59

0.05

miR-501–3p

1.62

1.02–2.58

0.048

miR-223

1.63

1.23–2.16

0.035

miR-133b

1.64

0.99–2.73

0.047

miR-574–3p

1.64

1.25–2.16

0.028

miR-579

1.66

1.01–2.73

0.037

miR-362–3p

1.67

1.08–2.58

0.05

miR-885–5p

1.69

1.06–2.70

0.029

miR-519d

1.70

1.04–2.77

0.041

miR-424

1.81

1.16–2.85

0.024

miR-886–5p

1.87

1.09–3.20

0.034

miR-191

1.87

1.30–2.69

0.021

miR-1

1.91

1.23–2.96

0.02

miR-200a

1.93

1.23–3.02

0.016

miR-302b

1.93

1.13–3.32

0.029

miR-107

1.96

1.25–3.05

0.03

miR-450b-3p

1.96

1.26–3.05

0.022

miR-582–5p

2.02

1.29–3.16

0.011

miR-145

2.09

1.11–3.93

0.045

miR-34a

2.50

1.63–3.83

0.021

miR-486–5p

2.70

1.3–5.59

0.039

Down-regulation

miR-31

0.32

0.19–0.54

0.002

  1. miR significantly altered in PBMC isolated from AAV patients (n = 20) as compared to healthy controls (n = 12). Mean fold change and its range in the patient group is listed.
Back to article page